Rocket Pharmaceuticals (RCKT) Other Accumulated Expenses (2014 - 2026)
Rocket Pharmaceuticals (RCKT) recorded Other Accumulated Expenses of $1.35 million in Q2 2026, down 21.1% from $1.71 million a year earlier and down 68.1% from the prior quarter.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Other Accumulated Expenses (2014 - 2026) Analysis & Trends
At the end of FY2025, Rocket Pharmaceuticals reported Other Accumulated Expenses of $2.33 million, up 43.4% from FY2024.
- Annual Other Accumulated Expenses has a five-year compound annual growth rate of 5.8% (FY2020 to FY2025).
- Across earlier years, Other Accumulated Expenses came in at $1.63 million in FY2024 (-8.3%), $1.77 million in FY2023 (-22.0%), $2.27 million in FY2022 (+213.5%) and $725,000 in FY2021 (-58.7%).
- The Q2 2026 figure is the lowest quarterly Other Accumulated Expenses since Q2 2023.
- On a year-over-year basis, Other Accumulated Expenses rose in four of the last eight quarters, with growth averaging 8.3%.
- Peak year-over-year performance for Other Accumulated Expenses in the last five years was growth of 213.5% in Q4 2022, against a decline of 80.3% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.22 million (Q1 2026), $2.33 million (Q4 2025) and $2.67 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Rocket Pharmaceuticals | 280.42 Mn | 280.42 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.35 Mn |
| Mar 31, 2026 | 4.22 Mn |
| Dec 31, 2025 | 2.33 Mn |
| Sep 30, 2025 | 2.67 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Mar 31, 2025 | 2.95 Mn |
| Dec 31, 2024 | 1.63 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Jun 30, 2024 | 3.06 Mn |
| Mar 31, 2024 | 2.75 Mn |
| Dec 31, 2023 | 1.77 Mn |
| Sep 30, 2023 | 1.85 Mn |
| Jun 30, 2023 | 1.27 Mn |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 2.27 Mn |
| Sep 30, 2022 | 1.88 Mn |
| Jun 30, 2022 | 645,000.00 |
| Mar 31, 2022 | 1.64 Mn |
| Dec 31, 2021 | 725,000.00 |
| Sep 30, 2021 | 1.11 Mn |
API Access
Rocket Pharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RCKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();